Cytochrome P450 1A1 (CYP1A1) inhibitor α-naphthoflavone interferes with UDP-glucuronosyltransferase (UGT) activity in intact but not in permeabilized hepatic microsomes from 3-methylcholanthrene-treated rats:: Possible involvement of UGT-P450 interactions

被引:23
作者
Taura, K
Naito, E
Ishii, Y
Mori, MA
Oguri, K
Yamada, H
机构
[1] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Univ, Sch Med, Dept Hlth Sci, Fukuoka 8128582, Japan
[3] Kyushu Univ Hlth & Welf, Sch Pharmaceut Sci, Miyazaki 8828508, Japan
关键词
interaction; UDP-glucuronosyltransferase (UGT); cytochrome P450 (CYP); inhibitor; membrane topology;
D O I
10.1248/bpb.27.56
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of cytochrome P450 (P450, CYP) ligands and permeabilization of microsomes on 3-hydroxybenzo(a)pyrene [3-OH-B(a)P] glucuronidation mediated by rat hepatic microsomes were studied. While the UDP-glucuronosyltransferase (UGT) activity with non-permeabilized microsomes from 3-methylcholanthrene ((MC)-treated rats was markedly reduced by m-naphthoflavone (NF), this inhibitor had hardly any effect when permeabilized microsomes were used in which the inhibitor was expected to have easy access to UGT. Kinetic analysis indicated that the inhibitory effect of alpha-NF is competitive. These results suggest that a UGT isoform(s) involved in 3-OH-B(a)P glucuronidation is interfered by a CYP1A inhibitor via a mechanism dependent on the intact nature of microsomal membranes in MC-treated rats. It is likely that P450 functions as a substrate transporter for some isoforms of UGT via possible interactions between UGT and P450.
引用
收藏
页码:56 / 60
页数:5
相关论文
共 44 条
  • [1] Membrane insertion of cytochrome P450 1A2 promoted by anionic phospholipids
    Ahn, T
    Guengerich, FP
    Yun, CH
    [J]. BIOCHEMISTRY, 1998, 37 (37) : 12860 - 12866
  • [2] ANALYSIS OF GENES FOR BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE IN GILBERTS-SYNDROME
    AONO, S
    ADACHI, Y
    UYAMA, E
    YAMADA, Y
    KEINO, H
    NANNO, T
    KOIWAI, O
    SATO, H
    [J]. LANCET, 1995, 345 (8955): : 958 - 959
  • [3] OXIDATION OF BENZO[A]PYRENE BY RECOMBINANT HUMAN CYTOCHROME-P450 ENZYMES
    BAUER, E
    GUO, ZY
    UENG, YF
    BELL, LC
    ZELDIN, D
    GUENGERICH, FP
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 1995, 8 (01) : 136 - 142
  • [4] ACTIVATION AND INDUCTION OF RAT-LIVER MICROSOMAL UDP-GLUCURONYLTRANSFERASE WITH 3-HYDROXYBENZO(A) PYRENE AND N-HYDROXY-2-NAPHTHLAMINE AS SUBSTRATES
    BOCK, KW
    LILIENBLUM, W
    [J]. BIOCHEMICAL PHARMACOLOGY, 1979, 28 (05) : 695 - 700
  • [5] Dutton GJ, 1980, GLUCURONIDATION DRUG
  • [6] DRUG-RESPONSIVE AND TISSUE-SPECIFIC ALTERNATIVE EXPRESSION OF MULTIPLE FIRST EXONS IN RAT UDP-GLUCURONOSYLTRANSFERASE FAMILY-1 (UGTI) GENE-COMPLEX
    EMI, Y
    IKUSHIRO, S
    IYANAGI, T
    [J]. JOURNAL OF BIOCHEMISTRY, 1995, 117 (02) : 392 - 399
  • [7] Homodimerization of human bilirubin-uridine-diphosphoglucuronate glucuronosyltransferase-1 (UGT1A1) and its functional implications
    Ghosh, SS
    Sappal, BS
    Kalpana, GV
    Lee, SW
    Chowdhury, JR
    Chowdhury, NR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (45) : 42108 - 42115
  • [8] Identification of a rat oltipraz-inducible UDP-glucuronosyltransferase (UGT1A7) with activity towards benzo(alpha)pyrene-7,8-dihydrodiol
    Grove, AD
    Kessler, FK
    Metz, RP
    Ritter, JK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) : 1621 - 1627
  • [9] SELECTIVE INHIBITORS OF CYTOCHROMES P450
    HALPERT, JR
    GUENGERICH, FP
    BEND, JR
    CORREIA, MA
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1994, 125 (02) : 163 - 175
  • [10] Alanine-scanning mutagenesis of a putative substrate recognition site in human cytochrome P450 3A4 - Role of residues 210 and 211 in flavonoid activation and substrate specificity
    Harlow, GR
    Halpert, JR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (09) : 5396 - 5402